Leading global drugmakers such as MSD Pharmaceuticals, Novartis, AstraZeneca, and Pfizer stand to benefit as it opens new opportunities to expand access to their medicines through PAPs.

In a significant shift in the global pharmaceutical landscape, a substantial portion of French medicines is now being ...

Simon-Kucher's industry study reveals barriers and success factors for improving global pricing and marketing access ...

The American CEO of Swiss drugmaker Novartis on Friday warned that the United States' exit from the World Health Organization ...

Venture Global LNG could finish power generator repairs by the end of February, a federal inspection report said on Wednesday ...

In a report released today, James Molloy from Alliance Global Partners initiated coverage with a Buy rating on CNS Pharmaceuticals (CNSP – ...

Alliance Global Partners initiated coverage of CNS Pharmaceuticals (CNSP) with a Buy rating and $4 price target CNS is a clinical-stage ...

Contrast agents like barium and iodine, which increase the visibility of medical imaging, are suffering from a global shortage, opening the growing US$6.3 billion dollar market up to new players ...

WASHINGTON, Jan. 16, 2025—Developing economies—which fuel 60 percent of global growth—are projected to finish the first quarter of the 21st century with the weakest long-term growth outlook since 2000 ...

China is deepening its regulatory reforms of drugs and devices to foster a globally competitive innovation ecosystem to transform China from a major pharmaceutical manufacturer into a global ...

Pharmaceutical manufacturing encompasses all processes involved in the manufacturing and production of biological and medical products, botanical drugs, and herbs, as well as other pharmaceutical ...

Despite this setback, the Act remains a critical piece of legislation in ongoing efforts to restructure global pharmaceutical supply chains. If it fails to advance this year, it may face further ...